Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis.
Graille-Avy L, Boutiere C, Rigollet C, Perriguey M, Rico A, Demortiere S, Durozard P, Hilezian F, Vely F, Bertault-Peres P, Pelletier J, Maarouf A, Audoin B. Graille-Avy L, et al. Among authors: audoin b. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200231. doi: 10.1212/NXI.0000000000200231. Epub 2024 Apr 16. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38626360 Free article.
Special issue introduction: Ultrafast photoacoustics.
Gusev VE, Audoin B, Wright OB. Gusev VE, et al. Among authors: audoin b. Photoacoustics. 2023 Dec 23;37:100581. doi: 10.1016/j.pacs.2023.100581. eCollection 2024 Jun. Photoacoustics. 2023. PMID: 38566828 Free PMC article. No abstract available.
Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis.
Demortiere S, Joubert B, Benaiteau M, Hilezian F, Boutiere C, Rico A, Stolowy N, Dubois V, Audoin B, Maarouf A, Pelletier J. Demortiere S, et al. Among authors: audoin b. Neurology. 2024 Apr 23;102(8):e209284. doi: 10.1212/WNL.0000000000209284. Epub 2024 Mar 25. Neurology. 2024. PMID: 38527243 No abstract available.
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
Jouvenot G, Courbon G, Lefort M, Rollot F, Casey R, Le Page E, Michel L, Edan G, de Seze J, Kremer L, Bigaut K, Vukusic S, Mathey G, Ciron J, Ruet A, Maillart E, Labauge P, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Stankoff B, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al-Khedr A, Casez O, Bourre B, Cabre P, Wahab A, Magy L, Camdessanché JP, Doghri I, Moulin S, Ben-Nasr H, Labeyrie C, Hankiewicz K, Neau JP, Pottier C, Nifle C, Collongues N, Kerbrat A; OFSEP Investigators. Jouvenot G, et al. JAMA Neurol. 2024 May 1;81(5):490-498. doi: 10.1001/jamaneurol.2024.0395. JAMA Neurol. 2024. PMID: 38526462
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
Collongues N, Durand-Dubief F, Lebrun-Frenay C, Audoin B, Ayrignac X, Bensa C, Bigaut K, Bourre B, Carra-Dallière C, Ciron J, Defer G, Kwiatkowski A, Leray E, Maillart E, Marignier R, Mathey G, Morel N, Thouvenot E, Zéphir H, Boucher J, Boutière C, Branger P, Da Silva A, Demortière S, Guillaume M, Hebant B, Januel E, Kerbrat A, Manchon E, Moisset X, Montcuquet A, Pierret C, Pique J, Poupart J, Prunis C, Roux T, Schmitt P, Androdias G, Cohen M. Collongues N, et al. Among authors: audoin b. Mult Scler. 2024 Feb 15:13524585231223880. doi: 10.1177/13524585231223880. Online ahead of print. Mult Scler. 2024. PMID: 38357870 Review.
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
Venet M, Lepine A, Maarouf A, Biotti D, Boutiere C, Casez O, Cohen M, Durozard P, Demortière S, Giorgi L, Maillart E, Mathey G, Mazzola L, Rico A, Camdessanche JP, Deiva K, Pelletier J, Audoin B. Venet M, et al. Among authors: audoin b. Mult Scler. 2024 Feb;30(2):261-265. doi: 10.1177/13524585231223069. Epub 2024 Jan 2. Mult Scler. 2024. PMID: 38166437
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder.
Carta S, Dinoto A, Capobianco M, Valentino P, Montarolo F, Sala A, Reindl M, Lo Re M, Chiodega V, Branger P, Audoin B, Aboab J, Papeix C, Collongues N, Kerschen P, Zephir H, Créange A, Bourre B, Schanda K, Flanagan EP, Redenbaugh V, Villacieros-Álvarez J, Arrambide G, Cobo-Calvo A, Ferrari S, Marignier R, Mariotto S. Carta S, et al. Among authors: audoin b. Neurol Neuroimmunol Neuroinflamm. 2024 Jan;11(1):e200188. doi: 10.1212/NXI.0000000000200188. Epub 2023 Dec 22. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38134369 Free PMC article.
191 results